Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: Results from the ACSRS study by Nicolaides A N et al.
*Correspond
Cyprus Instit
Nicosia, Cyp
E-mail address
1078–5884/00Severity of Asymptomatic Carotid Stenosis and Risk of
Ipsilateral Hemispheric Ischaemic Events: Results from the
ACSRS Study
A.N. Nicolaides,1,4* S.K. Kakkos,1 M. Griffin,1 M. Sabetai,1 S. Dhanjil,1 T. Tegos,1
D.J. Thomas,2 A. Giannoukas,1 G. Geroulakos,1,3 N. Georgiou,4 S. Francis,1
E. Ioannidou,4 C.J. Dore´5 and For the Asymptomatic Carotid Stenosis and Risk of
Stroke (ACSRS) Study GroupDepartments of 1Vascular Surgery, Imperial College, 2Neurology, St Mary’s Hospital, 3Vascular Surgery,
Ealing Hospital, London, UK; 4The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; and 5MRC
Clinical Trials Unit, London, UKObjectives. This study determines the risk of ipsilateral ischaemic neurological events in relation to the degree of
asymptomatic carotid stenosis and other risk factors.
Methods. Patients (nZ1115) with asymptomatic internal carotid artery (ICA) stenosis greater than 50% in relation to the
bulb diameter were followed up for a period of 6–84 (mean 37.1) months. Stenosis was graded using duplex, and clinical and
biochemical risk factors were recorded.
Results. The relationship between ICA stenosis and event rate is linear when stenosis is expressed by the ECST method, but
S-shaped if expressed by the NASCET method. In addition to the ECST grade of stenosis (RR 1.6; 95% CI 1.21–2.15),
history of contralateral TIAs (RR 3.0; 95% CI 1.90–4.73) and creatinine in excess of 85 mmol/L (RR 2.1; 95% CI 1.23–3.65)
were independent risk predictors. The combination of these three risk factors can identify a high-risk group (7.3% annual
event rate and 4.3% annual stroke rate) and a low risk group (2.3% annual event rate and 0.7% annual stroke rate).
Conclusions. Linearity between ECST per cent stenosis and risk makes this method for grading stenosis more amenable to
risk prediction without any transformation not only in clinical practice but also when multivariable analysis is to be used.
Identification of additional risk factors provides a new approach to risk stratification and should help refine the indications
for carotid endarterectomy.Keywords: Asymptomatic; Carotid; Stenosis; Risk; NASCET; ECST.Introduction
The degree of internal carotid artery (ICA) stenosis is a
well-established measurement used to assess the risk
of ipsilateral ischaemic neurological events1,2 and a
major criterion to decide whether carotid endarter-
ectomy is indicated.
Two main methods are currently used to express
percent diameter stenosis. The first one defines the
residual lumen as a percentage of the normal distal
ICA. It has been used in North America since the late
1960s and more recently the North American Sympto-
matic Carotid Endarterectomy Trial (NASCET)1 and
the Asymptomatic Carotid Atherosclerosis Studying author. Prof A.N. Nicolaides, MS, FRCS, The
ute of Neurology and Genetics, P.O. Box 23462, 1683
rus.
: anicolai@cing.ac.cy
0275+ 10 $35.00/0 q 2005 Elsevier Ltd. All rights reser(ACAS).2 It has become known as the North American,
‘NASCET’ or ‘N’ method.3 The second method
expresses the residual lumen as a percentage of the
diameter of the carotid bulb and has been used in the
European Carotid Surgery Trial (ECST)4 to become
known as the European or ‘ECST’ or ‘E’ method.5 The
relationship between both methods is shown in Fig. 1.
Several natural history studies6–15 indicate that the
risk of stroke in asymptomatic patients is low (0.1–
1.6% per year) for NASCET stenosis less than 75–80%
and higher (2.0–3.3% per year) with greater degrees of
stenosis. Different cut-off points, ranges andmethods of
grading stenosis have been used in these natural history
studies6–15 and randomized controlled trials.1,2,4,16
Universal agreement as to the best method for grading
ICA stenosis and optimum cut-off points in relation to
risk have not yet been established.
The aims of this paper based on data from theEur J Vasc Endovasc Surg 30, 275–284 (2005)
doi:10.1016/j.ejvs.2005.04.031, available online at http://www.sciencedirect.com onved.
Fig. 1. The relationship between ECST and NASCET %
stenosis. The conversion scale is based on the following
equations: NZ(ECST stenosisK43)!(100/57) and EZ
(NASCET % stenosis!(57/100)C43) (note: a 43% stenosis
of the bulb reduces the lumen to the diameter of the lumen of
the normal distal internal carotid artery).
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(ACSRS) natural history study17 are to determine:(a)Eur Jthe risk of ipsilateral ischaemic hemispheric
neurological events associated with different
degrees of ICA stenosis,(b) which method of expressing percent stenosis
provides a better expression of risk,(c) which are the most appropriate ranges of stenosis
for grouping patients at different risk, and(d) whether any independent clinical or biochemical
risk factors can be used in conjunction with the
degree of stenosis to improve risk prediction.Material and MethodsAims of ACSRS study
The asymptomatic carotid stenosis and risk of stroke
(ACSRS) is an ongoing international multicentre study
under the auspices of the International Union of
Angiology. Patients with asymptomatic 50–99% ste-
nosis in relation to the carotid bulb diameter (ECST)
are followed for at least 5 years to identify subgroups
at high and low risk for future neurological events.Vasc Endovasc Surg Vol 30, September 2005Approval has been obtained from the Multicenter
Research Ethics Committee (North Thames, London,
UK) and local ethics committees. Patients were
admitted to the study after informed consent. The
methodology used in the ACSRS study, eligibility of
participating centres and quality control have been
published in detail previously.17 Only an outline of the
methodology and results related to the degree of ICA
stenosis are presented in this paper.Admission to the study
Patients with ICA stenosis greater than 50% (ECST) on
duplex scanning who never had any ipsilateral
hemispheric or retinal symptoms and did not have
any neurological abnormality on examination were
eligible for admission to the study. Patients who had
contralateral hemispheric symptoms were also
included provided they had been asymptomatic for
at least 6 months at the time of recruitment. The ratio
of patients with stenosis 50–69 and 70–99% recruited
into the study from any centre had to be 1:2 in order to
avoid any selection bias from centres that had a policy
to operate on patients with severe asymptomatic
stenosis. The side with the more severe stenosis was
considered to be the ipsilateral side for any patient
with bilateral stenosis.Risk factors and non-invasive investigations
The following clinical risk factors and their duration
and severity were recorded for each patient: age,
gender, height and weight, hypertension, cardiac
status (history of myocardial infarction or angina),
diabetes, smoking, fibrinogen, fasting blood choles-
terol, HDL, LDL, triglycerides, creatinine and
haematocrit.
Duplex scanning was performed on admission to
the study and subsequently every 6 months to grade
ICA stenosis. The team that included a neurologist
reviewed each patient at all visits to provide clinical
information to document the rate of progression of
ICA stenosis. Velocity criteria for grading the degree of
stenosis are summarized in Table 1.3 Because absolute
velocity measurements could underestimate stenosis
(e.g. in the presence of cardiac arrhythmia) or over-
estimate stenosis (e.g. in the presence of severe
contralateral disease), ultrasonographers at each
centre were trained to use a combination of absolute
velocity measurements and velocity ratios.3,18–25
Characteristics of vertebral artery flow whether
cephalad, reversed or absent were also recorded. The
entire duplex examination was recorded on videotape.
Table 1. Duplex velocity criteria selected for highest accuracy* (from Nicolaides et al., 1996)3
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Primary endpoints were ipsilateral hemispheric
ischaemic stroke (including fatal stroke) defined as a
hemispheric neurological deficit lasting for more than
24 h, any stroke, ipsilateral hemispheric TIAs, amauro-
sis fugax and death from cardiovascular causes other
than stroke.17 For reported strokes a special form was
filled locally and two members of the coordinating
team, which included a neurologist made the final
classification. The local team made the diagnosis of
TIAs or amaurosis fugax.Exit points
Exit points are any of the above endpoints, death from
any cause, ipsilateral carotid endarterectomy or stent-
ing. Patients who had carotid endarterectomy or
stenting were excluded from subsequent analysis, as
they would no longer be contributing to the natural
history of asymptomatic carotid stenosis.Quality control
The ultrasound methodology in the ACSRS study
includes a set of procedures designed to control
quality and monitor key components of measure-
ments. These include instrumentation settings,
method of recording data, standardization of the
method of scanning and personnel training at the
coordinating centre. Throughout the study’s perform-
ance is compared to the set standards. Results of thequality control, already published,17 indicate that the
goal of prospectively controlling quality in the ACSRS
Study has been achieved.Statistical analysis
The SPSS for Windows (release 10.01 Chicago, Ill,
USA) statistical package was used throughout. The
chi-square test was used to test the significance of the
incidence of event rates in relation to grades of stenosis
(Tables 2–4) and in univariate analyses between
clinical risk factors and neurological events. Kaplan–
Meier curves were used for event-free survival rates
and log rank tests for significance of difference
between curves. Cox regression analysis was used to
determine which clinical and biochemical risk factors
as well as stenosis were independent predictors of
risk. The level of significance was considered as
p%0.05.Role of the funding source
The sponsors of the study had no role in the study
design, data collection, data analysis, data interpret-
ation, writing of the report or decision to submit the
report for publication.Results
The results presented in this paper are based on the
first 1115 patients recruited with a follow-up of 6–84Eur J Vasc Endovasc Surg Vol 30, September 2005
Table 2. The number of different ipsilateral ischaemic hemispheric neurological events in relation to the ECST method of grading
internal carotid artery stenosis (chi-square 13.4; pZ0.037)
% ECST stenosis AF TIA Stroke All events All patients
50–69 3 (1.5%) 4 (2.1%) 3 (1.5%) 10 (5.1%) 194
70–89 6 (1.0%) 25 (4.2%) 23 (3.9%) 54 (9.1%) 593
90–99 9 (2.7%) 15 (4.6%) 20 (6.1%) 44 (13.4%) 328
Total 18 (1.6%) 44 (3.9%) 46 (4.1%) 108 (9.7%) 1115
A. N. Nicolaides et al.278months (mean 37.1). A total of 108 ipsilateral hemi-
spheric events have occurred: 18 were amaurosis
fugax (AF), 44 TIAs and 48 strokes of which 46 were
ischaemic (eight fatal) and two were haemorrhagic
(both fatal). There have been a total of 163 deaths of
which 105 were due to cardiovascular causes. Ipsilat-
eral carotid endarterectomy has been performed in 116
patients with severe stenosis (median: 85% in relation
to the bulb; interquartile range: 75–90) because the
doctor or the patient requested it despite absence of
neurological events. This was particularly so after
publication of the ACST results. Eighteen patients
have been lost to follow-up: six at 6 months, two at 12
months, one at 18 months, one at 24 months, three at 30
months, four at 36 months and one at 72 months. Of
the 18 patients contact was lost with 12, five declined
to re-attend and one emigrated. The number of
patients followed up is 1115 for 6 months, 964 for 12
months, 851 for 18 months, 745 for 24 months, 640 for
30 months, 543 for 36 months, 459 for 42 months, 376
for 48 months, 323 for 54 months, 246 for 60 months,
147 for 66 months, 90 for 72 months, 43 for 78 months
and 27 for 84 months.Relation to ICA stenosis
The numbers of different ipsilateral ischaemic hemi-
spheric neurological events in relation to stenosis
expressed by the ECST and NASCET methods are
listed in Tables 2 and 3, respectively. The incidence of
ipsilateral hemispheric events appears to have a linear
relationship with ECST stenosis (Fig. 2(A)), but not
with NASCET stenosis (Fig. 2(B)). The cumulative
event free-survival rate for all ipsilateral events in
relation to the ECST and NASCET methods for
stenosis is shown in Fig. 3. Fig. 3(B) demonstratesTable 3. The number of different ipsilateral ischaemic hemispheric n
internal carotid artery stenosis (chi-square 27.9; pZ0.007)
% NASCET stenosis AF TIA
!30 1 (1.0%) 1 (1.0%)
30–49 3 (1.4%) 6 (2.9%)
50–69 3 (0.9%) 14 (4.0%)
70–89 8 (2.3%) 18 (5.2%)
90–99 3 (2.8%) 5 (4.6%)
Total 18 (1.6%) 44 (3.9%)
Eur J Vasc Endovasc Surg Vol 30, September 2005that there is little difference in the event-free survival
rate between the groups with NASCET percent
stenosis 30–49, 50–69 and 70–89%.
Table 4 lists the number of different ipsilateral
ischaemic hemispheric neurological events and Fig.
3(c) the cumulative event-free survival rate in relation
to less than 60 and 60–99% NASCET stenosis,
respectively. The difference is significant (pZ0.022,
log rank test) but it is apparent that the 60% selection
criterion for carotid endarterectomy recommended
from the ACAS trial is not a good discriminator of risk
since 37 (34%) of all 108 events have occurred in the
group of patients with stenosis less than 60% by the
NASCET method (Table 4).
Fig. 3(A) shows the cumulative event-free survival
rate in relation to three groups: (a) 50–69% ECST
equivalent to 12–46% NASCET, (b) 70–89% ECST
equivalent to 47–81% NASCET and (c) 90–99%
ECST equivalent to 82–99% NASCET. Classification
into these three groups identifies a low risk group (a)
with a 7-year cumulative event rate of 8%, a moderate
risk group (b) with a 7-year cumulative event rate of
18% and a high-risk group (c) with a 7-year cumulative
event rate of 35%.Other potential risk factors
Age, gender, hypertension, cardiac symptoms, atrial
fibrillation, diabetes, smoking, pack-years, fibrinogen,
fasting total cholesterol, HDL, LDL, triglycerides, BMI
and contralateral stenosis of any degree or occlusion
were not associated with an increased incidence of
ipsilateral ischaemic hemispheric neurological events
in a univariate analysis using chi-square and log rank
tests; a history of contralateral hemispheric TIAs at
least 6 months prior to admission to the study andeurological events in relation to the NASCET method of grading
Stroke All events All patients
2 (2.0%) 4 (4.0%) 101
8 (3.8%) 17 (8.1%) 209
12 (3.4%) 29 (8.2%) 352
11 (3.2%) 37 (10.7%) 344
13 (11.9) 21 (19.3%) 109
46 (4.1%) 108 (9.7%) 1115
Table 4. The number of different ipsilateral ischaemic hemispheric neurological events in relation to less than 60 and 60–99% NASCET
internal carotid artery stenosis (chi-square 4.6; pZ0.21)
% NASCET stenosis AF TIA Stroke All events All patients
!60 6 (1.2%) 15 (3.0%) 16 (3.2%) 37 (7.4%) 499
60–99 12 (1.9%) 29 (4.6%) 30 (4.7%) 71 (11.2%) 636
Total 18 (1.6%) 44 (3.9%) 46 (4.1%) 108 (9.7%) 1115
 
 
 
 
 
 
 
Fig. 2. The incidence of ipsilateral ischaemic hemispheric events (A) in relation to the ECST % stenosis of the internal carotid
artery and (B) in relation to the NASCET % stenosis of the internal carotid artery.
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Fig. 3. (A) The ipsilateral hemispheric event-free cumulative
survival rate in relation to the ECST% stenosis of the internal
carotid artery (50–69% group: nZ101; 70–89% group: nZ593;
90–99% group: nZ328). Overall log rank: 11.7 pZ0.0026; 50–
69 vs 79–89% pZ0.045; 79–89 vs 90–99% pZ0.020; 50–69 vs
90–99% pZ0.0014; (B) the ipsilateral hemispheric event free
cumulative survival rate in relation to the NASCET %
stenosis of the internal carotid artery (12–30% group: nZ101;
30–49% group: nZ209; 50–69% group: nZ352; 70–89%
group: nZ354; 90–99% group: nZ109). Overall log rank:
A. N. Nicolaides et al.280
Eur J Vasc Endovasc Surg Vol 30, September 2005elevated creatinine levels were (Fig. 4). The best cut off
level for creatinine as determined by an ROC curve
was 85 mmol/L.
In a Cox regression analysis all three factors:
severity of ipsilateral stenosis (ECST), history of
contralateral hemispheric TIAs and creatinine were
independent predictors of risk (Table 5). Thus, after
adjusting for confounding variables stenosis remained
significant. Based on this Cox regression model the
linear risk predictor score (x*Beta) (SPSS version 10.01)
was calculated for every patient. This score is the sum
of the product of mean-centered covariance values and
their corresponding parameter estimates for each
patient. The upper quartile of this score consisted of
a high-risk group with a 44% cumulative event rate at
6 years and the remaining lower three quartiles
consisted of a low-risk group with a 14% cumulative
event rate at 6 years (Fig. 5). Fifty events including 25
strokes were in the high-risk group. Fifty-eight of the
events including 21 strokes were in the low-risk group.Discussion
The results of the ACSRS study demonstrate that the
risk of ipsilateral ischaemic hemispheric events rises
with increasing severity of ICA stenosis (Tables 2–3
and Fig. 2) and confirm the findings of previous
natural history studies6–13 irrespective of different cut-
off points used: 50,6,8,10–13 7510,11 and 80%9 in relation
to the distal internal carotid or 5012 and 80%12 in
relation to the bulb.
The NASCET randomised controlled study used
angiography and a cut-off point of 70% stenosis in
relation to the distal internal carotid which is
equivalent to 83% stenosis in relation to the bulb.
The ECST randomised controlled study used angio-
graphy also but a cut-off point of 70% stenosis in
relation to the bulb which is equivalent to 47% stenosis
in relation to the distal internal carotid artery. Many
vascular surgeons are under the impression that these
cut-off points are similar! The only similarity is the
value of 70%. In reality the difference in terms of
plaque size or residual lumen is considerable. How-
ever, with increasing degrees of stenosis the values of11.7 pZ0.0026; statistical significance between the four lower
grades of stenosis pO0.1; 90–99% vs any other group p!0.01;
(C) the ipsilateral hemispheric event free cumulative
survival rate in relation to the NASCET % stenosis of the
internal carotid artery (!60% group: nZ497; 60–99% group:
nZ636). Log rank: 5.2 pZ0.022. In view of the small number
of patients that have been followed for 7 years (nZ27) the
abrupt drop in the survival curve should be ignored.
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decreases (Fig. 1).
The method of expressing stenosis as a percentage
of the distal internal carotid dates back to the 1960s
when angiography was the only imaging method
available.26,27 It was a standard method in North
America until duplex ultrasound became available.
The duplex velocity criteria for grading internal
carotid artery stenosis developed by Strandness and
his team in the 1980s were in relation to the percent
stenosis of the bulb.18 Their gold standard was
angiography and microcalcification in the arterial
wall was used to define the outline of the bulb. SeveralFig. 4. (A) The ipsilateral hemispheric event-free cumulative
survival rate in relation to the presence or absence of history
of contralateral TIAs 6 months or more before admission to
the study (history absent: nZ1014; history present: nZ101).
Log rank: 26.7 pZ0.00001; (B) The ipsilateral hemispheric
event free cumulative survival rate in relation to the
creatinine plasma levels (!85 mmol/L group: nZ283;
O85 mmol/L group: nZ835). Log rank: 7.8 pZ0.0051. In
view of the small number of patients that have been followed
for 7 years (nZ27) the abrupt drop in the survival curve
should be ignored.
Fig. 5. The ipsilateral hemispheric event free cumulative
survival rate in relation to the risk (Cox x*Beta) calculated for
each patient according to the Cox regression model shown in
Table 5. Upper quartile vs lower three quartiles of risk: log
rank: 27.5 p!0.0001 (50 events including 25 strokes are in the
upper quartile and 58 events including 21 strokes are in the
rest of the population). In view of the small number of
patients that have been followed for 7 years (nZ27) the
abrupt drop in the survival curve should be ignored.studies have since redefined the velocity criteria in
terms of percent stenosis of the distal internal carotid
(Table 1). It can be seen in Table 1 that the velocity
criteria for 70% stenosis ‘NASCET’ are very different
from 70% stenosis ‘ECST’.
Radiology departments and vascular laboratories
often express the results of angiography or duplex
ultrasound as ‘percent stenosis’ without any indi-
cation whether the ‘percent stenosis’ is expressed in
terms of the bulb or the distal internal carotid. The
ACST randomised controlled study used duplex to
grade the degree of stenosis with 70% as the cut-off
point, but neither the velocity criteria nor what 70%
stenosis refers to (bulb or distal internal carotid) has
been stated.16 Without such a statement it is not
possible to knowwhether some teams were expressing
their results as percent stenosis of the bulb and others
of the internal carotid. Much needs to be done in terms
of education on this issue and for standardisation of
methods published in vascular journals.
The results of the present study suggest that
contralateral symptoms imply an inherent predisposi-
tion with increased risk for the ipsilateral asympto-
matic side irrespective of the degree of stenosis. This is
supported by the finding that the annual stroke rate on
the asymptomatic side of the ECST14 and NASCET15
studies in which patients presented initially with
unilateral hemispheric symptoms was 1.5–2.0 times
higher than the risk in studies of bilaterally asympto-
matic patients.10–13 It is further supported by theEur J Vasc Endovasc Surg Vol 30, September 2005
Table 5. Results of Cox regression analysis with ipsilateral ischaemic hemispheric neurological events as the dependent variable; ECST
stenosis (three groups: 50–69, 70–89, 90–99%), creatinine (two groups: !85 mmol/L, O85 mmol/L) and history of contralateral TIAs 6
months or more prior to admission to the study were the independent variables
Independent variables B SE p Exp(B) 95% CI for exp(B)
ECST stenosis 0.480 0.15 0.001 1.615 1.21–2.15
History of contralateral TIAs 1.099 0.23 0.0001 3.002 1.90–4.73
Creatinine 0.749 0.27 0.007 2.116 1.23–3.65
A. N. Nicolaides et al.282finding that in the control group of the ACST16 the
ipsilateral stroke rate was double in those with a
history of contralateral symptoms than those without.
The relationship between stenosis and event rate is
linear if expressed as ECST per cent stenosis (Fig. 2(A)),
but it is S-shaped if expressed as NASCET per cent
stenosis (Fig. 2(B)). Linearity between ECST per
cent stenosis and risk makes this method for grading
stenosis more amenable to risk prediction without any
transformation not only in clinical practice but also
when linear logistic or Cox regression analysis is to be
used.
The results of the ACSRS study, like previous
natural history studies which included patients with
lesions up to 99% stenosis,6,8–12 demonstrate that a
considerable number of events occur at low grades of
stenosis. In fact 37 (34%) of 108 ipsilateral ischaemic
hemispheric events including 16 (35%) of the 46
strokes (Table 4) occurred in patients with stenosis
less than 60% NASCET (!77% ECST), the selection
criterion for carotid endarterectomy in asymptomatic
patients as indicated from the findings of the ACAS
trial. Only 10 (9%) of the events including 3 (3%)
strokes occurred in patients with stenosis less than
70% ECST equivalent to approximately 50% NASCET
(Table 2). This is because the 60% NASCET cut-off
point is in the middle of the moderate risk-group
(Fig. 3(B)). In contrast, the ECST 70% cut-off point is in
the lower end of the moderate-risk group (Fig. 3(A)).
Of the clinical and biochemical risk factors studied
only two were associated with an increased overall
event rate in a univariate analysis: history of contral-
ateral TIAs (Fig. 4(A)) and creatinine levels (Fig. 4(B)).
The fact that most of the established clinical and
biochemical risk factors for atherosclerosis were not
associated with an increased event rate is not surpris-
ing because these risk factors are present in the
majority of patients in the study who are all
arteriopaths. All three risk factors, stenosis (ECST),
history of contralateral TIAs and creatinine remained
significant independent predictors in a Cox regression
analysis (Table 5). Table 5 indicates that the relative
risk between ECST 50–69 and 70–89% or between 70–
89 and 90–99% stenosis is 1.6; also, the risk increases
three times if there is a history of contralateral TIAs
and 2.1 times if creatinine is higher than 85 mmol/L.Eur J Vasc Endovasc Surg Vol 30, September 2005Epidemiology studies have demonstrated that mild
to moderately raised serum creatinine is an indepen-
dent predictor of cardiovascular risk and particularly
ischaemic stroke.28,29 A more recent study has demon-
strated that elevated serum creatinine levels even
within the normal range are associated with an
increased risk of stroke in both normotensive and
hypertensive men.30
The combination of all three significant risk factors
(stenosis, history of ipsilateral TIAs and creatinine)
allows one to identify a high-risk group with a 44%
cumulative event rate at 7 years (7.3% annual event
rate) and a low-risk group with a 14% cumulative
event rate at 7 years (2.3% annual event rate). The
cumulative stroke rate at 7 years is 26% (4.3% annual
stroke rate) in the high-risk group and 4.2% (0.7%
annual stroke rate) in the low risk group. However,
this means that only 46% of all events including 54% of
the strokes were in the high-risk group, the rest
occurring in the low risk group. The contribution of
plaque characterisation using image normalisation
and texture feature extraction techniques in improving
these findings so that a high-risk group can be
identified that contains the majority of the strokes31
will be the subject of another paper.
The potential practical implications of the above
findings are as follows. In patients with 50–69% ECST
stenosis even in the presence of a history of contral-
ateral TIAs or creatinine in excess of 85 mmol/L or in
the presence of both, the annual stroke rate is not
higher than 1%. In patients with 70–89% ECST
stenosis, in the presence of a history of contralateral
TIAs and creatinine in excess of 85 mmol/L the annual
stroke rate is 3.2%. In the rest of the patients with 70–
89% ECSTstenosis even when one of the other two risk
factors is present the annual stroke rate is not higher
than 1.5%. In patients with 90–99% ECST stenosis, in
the absence of a history of contralateral TIAs and with
creatinine less than 85 mmol/L the annual stroke rate is
1%; in the presence of creatinine in excess of
85 mmol/L it is 2.2% and in the presence of a history
of contralateral TIAs it is 2.6%. In the presence of both,
history of contralateral TIAs and creatinine in excess of
85 mmol/L the annual stroke rate is 6.3%.
Our findings on risk assessment from the ACSRS
study need to be validated by other natural history
Asymptomatic Carotid Stenosis and Risk of Stroke 283studies, the control group of the ACST study and the
asymptomatic sides of the ECSTand NASCET trials. If
confirmed, they will provide a new approach to risk
stratification and may help refine the indications for
carotid endarterectomy.Acknowledgements
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